Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

  title={Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use},
  author={J. Gudin and S. Mogali and J. Jones and S. Comer},
  journal={Postgraduate Medicine},
  pages={115 - 130}
  • J. Gudin, S. Mogali, +1 author S. Comer
  • Published 2013
  • Medicine
  • Postgraduate Medicine
  • Abstract The concurrent use of opioids, benzodiazepines (BZDs), and/or alcohol poses a formidable challenge for clinicians who manage chronic pain. While the escalating use of opioid analgesics for the treatment of chronic pain and the concomitant rise in opioid-related abuse and misuse are widely recognized trends, the contribution of combination use of BZDs, alcohol, and/or other sedative agents to opioid-related morbidity and mortality is underappreciated, even when these agents are used… CONTINUE READING
    145 Citations
    Opioid Toxicity
    • 14
    • PDF
    Co-use of Alcohol and Opioids
    • 9
    • PDF
    Risk factors for concurrent use of benzodiazepines and opioids among individuals under community corrections supervision.
    • 12


    Considering the risks of benzodiazepines and opioids together.
    • 18
    • PDF
    Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.
    • 81
    Urine drug testing in chronic pain.
    • 153
    Polydrug abuse: a review of opioid and benzodiazepine combination use.
    • 417
    • PDF
    American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression.
    • 212
    • PDF
    Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
    • 1,854
    • PDF